Ticker Scorecard - CTXR Basics Company: Citius Pharmaceuticals, Inc. IPO Date: June 9, 2017 Sector: Healthcare Industry: Biotech Market Cap: $24.19M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 4.12% Avg Daily Range (30 D): $0.15 | 4.60% Avg Daily Range (90 D): $0.08 | 5.27% Institutional Daily Volume Avg Daily Volume: .07M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 17 Avg Trade Size (Sh.) (30 D): 139 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 45 Avg Inst. Trade: $2.78M Avg Inst. Trade (30 D): $6.8M Avg Inst. Trade (90 D): $6.8M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.35M Avg Closing Trade (30 D): $6.8M Avg Closing Trade (90 D): $6.8M Avg Closing Volume: 149.91K     News Jan 7, 2025 @ 1:08 PM Citius Pharmaceuticals and Citius Oncology Highlig... Source: Prnewswire Jul 31, 2023 @ 7:30 PM Why Apellis Pharmaceuticals Shares Are Trading Lo... Source: Lisa Levin Jul 31, 2023 @ 12:31 PM Why China Natural Resources Shares Are Trading Hig... Source: Lisa Levin Jul 31, 2023 @ 11:13 AM CSX, Citius Pharmaceuticals And Other Big Stocks M... Source: Lisa Levin Apr 25, 2023 @ 12:03 PM Why Aaron's Shares Are Trading Higher By Around 10... Source: Lisa Levin Financials   TTM Q4 2024 FY 2024 Basic EPS $-5.97 $-5.97 Diluted EPS $-5.97 $-5.97 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -39.43M $ -11.08M $ -39.43M Operating Income / Loss $ -42M $ -11.05M $ -42M Cost of Revenue $ $ $ Net Cash Flow $ -23.23M $ -23.23M $ -23.23M PE Ratio     Splits Nov 26, 2024:   25:1 Jun 09, 2017:   15:1 Sep 12, 2014:   8:5